Related Experiment Videos
Five novel point mutations: two causing haemophilia B and three causing factor X deficiency
M W Odom1, G Leone, V De Stefano
1Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio 78284.
Molecular and Cellular Probes
|February 1, 1994
Summary
This study identified five novel mutations in the factor IX and factor X genes, providing new insights into the molecular basis of bleeding disorders like hemophilia B. These findings advance our understanding of coagulation factor deficiencies.
Area of Science:
- Biochemistry
- Genetics
- Hematology
Background:
- Factor IX and X are crucial glycoproteins in the coagulation cascade.
- Deficiencies in these factors cause bleeding disorders of variable severity.
- Limited mutations causing factor X deficiency are characterized compared to factor IX deficiency (hemophilia B).
Purpose of the Study:
- To investigate the molecular basis of factor IX and factor X deficiencies in patients.
- To identify novel mutations in the genes encoding factor IX and factor X.
Main Methods:
- Enzymatic amplification and polymerase chain reaction (PCR) were used to amplify specific gene regions.
- Amplified DNA segments were cloned into pUC18 and sequenced.
- Genomic DNA from four patients (two with factor IX deficiency, two with factor X deficiency) was analyzed.
Main Results:
- Five novel point mutations were identified: two in the factor IX gene and three in the factor X gene.
- All identified mutations were located in the eighth exon of their respective genes.
- One mutation in each gene altered homologous histidine residues near the catalytic triad's serine.
Conclusions:
- This study expands the known spectrum of mutations causing factor IX and factor X deficiencies.
- The identified mutations provide a deeper understanding of the molecular mechanisms underlying these bleeding disorders.
- Alterations in critical residues like histidine may impact protein function and coagulation activity.